1.65
price up icon11.49%   0.17
pre-market  プレマーケット:  1.63   -0.02   -1.21%
loading
前日終値:
$1.48
開ける:
$1.56
24時間の取引高:
432.52K
Relative Volume:
0.31
時価総額:
$118.06M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+7.14%
1か月 パフォーマンス:
-37.26%
6か月 パフォーマンス:
+25.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$1.47
$1.70
1週間の範囲:
Value
$1.35
$1.8199
52週間の値動き範囲:
Value
$0.5506
$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name
名前
Citius Oncology Inc
Name
セクター
Healthcare (1161)
Name
電話
(908) 967-6677
Name
住所
11 COMMERCE DRIVE, CRANFORD
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CTOR's Discussions on Twitter

CTOR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
1.65 110.19M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-27 開始されました Maxim Group Buy

Citius Oncology Inc (CTOR) 最新ニュース

pulisher
Jul 22, 2025

Is Citius Oncology Inc. a good long term investmentTriple-digit profit margins - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Citius Oncology Inc. Stock Analysis and ForecastFree Stock Market Query - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Citius Oncology Inc. stockFree Wealth Management Insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Citius Oncology Inc. stock pricePowerful profit generation - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - Eastern Progress

Jul 19, 2025
pulisher
Jul 18, 2025

Citius Oncology shares rise 1.31% after-hours after closing a $9.0 million public offering. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Should I buy Citius Oncology Inc. stock before earningsShort Term High Return Strategy - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Citius Oncology Completes $9M Public Offering - TipRanks

Jul 18, 2025
pulisher
Jul 17, 2025

Citius Oncology launches $15M equity and warrant offering; shares down - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Closing Of $9.0 Million Public Offering - Barchart.com

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Jul 17, 2025
pulisher
Jul 16, 2025

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology’s Chances: Time to Invest? - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - PR Newswire

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Soars 35.06% on Distribution Deal - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Soars 12.34% on Expanded Lymphir Distribution - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Citius Oncology Inc. stock price move sharplySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Citius Oncology Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Shares Climb Following Expansion of LYMPHIR Distribution Network - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

How Citius Oncology Inc. stock performs during market volatilityLow Risk Entry Points - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Cencora distribution deal boosts Citius shares - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - Finansavisen

Jul 15, 2025
pulisher
Jul 14, 2025

Citius Oncology shares rise 4.64% after-hours despite plans for stock offering. - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

CTOR Crashes 34%—Is This the Breaking Point for Citius Oncology? - AInvest

Jul 14, 2025

Citius Oncology Inc (CTOR) 財務データ

Citius Oncology Inc (CTOR) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$72.34
price up icon 1.09%
$14.93
price up icon 1.70%
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
$132.75
price up icon 0.70%
$297.89
price up icon 1.63%
大文字化:     |  ボリューム (24 時間):